NEW TB VACCINE DEVELOPED
November 1st, 2012
BY KEITH NUTHALL
A EUROPEAN Union (EU)-funded research consortium is developing the first tuberculosis vaccine based on mycobacterium tuberculosis, the bacterium that causes TB. Switzerland's medicines authority Swissmedic has now authorised clinical trials in healthy adult volunteers. The project has been financed funded through the through the NEWTBVAC project, which has received Euro EUR12 million from the EU,and it has been coordinated by the TuBerculosis Vaccine Initiative (TBVI), a collaborative Europe-based consortium developing new TB ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.